[{"id":"tempus","kind":"company","name":"Tempus AI","route":"/companies/tempus/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/companies.ts","type":"changed","fields":[{"field":"summary","before":"\"xT (648-gene), xR (RNA), xF/xM (liquid, MRD), TIME trial matching, Tempus ECG-AF and other algorithms; Ambry Genetics (germline).\"","after":"\"Tempus sells xT (648-gene), xR (RNA), xF/xM (liquid, MRD), TIME trial matching, Tempus ECG-AF and other algorithms, and owns Ambry Genetics (germline).\""}]},{"id":"tempus","kind":"company","name":"Tempus AI","route":"/companies/tempus/","commit":"815a2a8bae","date":"2026-09-05","author":"Jude Gomila","message":"OnCo: open map of oncology — corpus (642 objects, 14 kinds), graph, static site, API, TNBC spike","file":"src/data/companies.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"hq"},{"field":"country"},{"field":"companyType"},{"field":"website"},{"field":"ticker"},{"field":"sections"},{"field":"tldr"},{"field":"summary"},{"field":"technologies"}]}]